A multicenter randomized study comparing the dose dense, G-CSF [filgrastim]-supported sequential administration of FE75C [fluorouracil + epirubicin + cyclophosphamide] followed by docetaxel versus paclitaxel as adjuvant chemotherapy in women with axillary lymph node positive breast cancer
Phase of Trial: Phase III
Latest Information Update: 08 Dec 2012
At a glance
- Drugs Docetaxel (Primary) ; Paclitaxel (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Early breast cancer
- Focus Therapeutic Use
- 08 Dec 2012 Results presented at the 35th Annual San Antonio Breast Cancer Symposium.
- 22 Nov 2007 Status changed from recruiting to completed.
- 08 Mar 2007 New trial record.